|
|
|
WASHINGTON, Nov 7 (Reuters) - The Senate must also vote on its version of a bill, which is not expected until December at the earliest, and both chambers would then meet to work out a final measure. Following are some of the...
Hank McKinnell helped pioneer the age of blockbuster drugs. As BusinessWeek went to press, the Food & Drug Administration was holding contentious hearings about the fate of some of the biggest-selling and most lavishly promoted...
WASHINGTON – Sen. Evan Bayh, D-Ind., has more than $12.7 million on hand to launch a re-election campaign next year, when he hopes Hoosiers will rehire him for a third six-year term. Two Republicans vying for the GOP nomination...
By Bruce Japsen Tribune staff reporter this morning confirmed the company's sales and marketing practices of Depakote, the widely used drug to treat bipolar disorder and epilepsy, are under federal investigation. The U.S....
will move its corporate headquarters into a new office building along the Dallas North Tollway in Plano. Alliance has leased about 84,000 square feet in One Legacy Circle, an eight-floor building developed by Trammell Crow Co....
Companies have cut costs to the bone in this brutal recession. Construction equipment giant Caterpillar Inc., based in Peoria, Ill., improved its image with Wall Street through extensive cost-cutting, even though third-quarter...
LYNBROOK, N.Y., Nov. 6 /PRNewswire-FirstCall/ -- BioSpecifics Technologies Corp. , a biopharmaceutical company developing first-in-class collagenase-based products, today announced its financial results for the third quarter...
Simon Houpt tracks the latest trends in the world of marketing and advertising It used to be that an overturned car in the Junction district of Toronto wouldn't be a big deal. Quoted: Harry Rosen's expensive lesson “Oh my God,...
MARTINSRIED/MUNICH, GERMANY and PRINCETON, NJ and HOUSTON, TX, Nov 06, 2009 (MARKETWIRE via COMTEX) -- Financial update The Company reported that Agennix AG's cash and cash equivalents position (pro forma) at September 30, 2009...
Steven Nissen's industry ties don't stop him from questioning drugs like Celebrex At a time when drugmakers are under fire for selling risky products, Dr. Steven E. Nissen occupies a unique position. A cardiologist at the...
